Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 743-746

  Del Freo, Alfonso ^a   Fiorentini, Giammaria ^b   Sanguinetti, Franco ^a   Muttini, Maria Pia ^a   Pennucci, Cristina ^a   Mambrini, Andrea ^a   Pacetti, Paola ^a   Della Seta, Roberta ^a   Lombardi, Mirko ^a   Torri, Tito ^a   Cantore, Maurizio ^a  

^a ASL 01   (Italy)

^b ASL 11   (Italy)

Author keywords

Colorectal cancer; Hepatic arterial chemotherapy; Oxaliplatin

Indexed keywords

DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; GRANISETRON; IRINOTECAN; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANAPHYLAXIS; ANEMIA; ARTERY CATHETERIZATION; ARTICLE; ASTHENIA; AXILLARY ARTERY; CANCER INHIBITION; CANCER SURVIVAL; CATHETER THROMBOSIS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG RESPONSE; DRUG SAFETY; FATIGUE; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERY; HEPATIC ARTERY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LIVER TOXICITY; MALE; NAUSEA AND VOMITING; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PHASE 2 CLINICAL TRIAL; SENSORY NEUROPATHY; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA; VASCULAR ACCESS;

EID: 33846040846     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F and Bismuth F: Five-year survival following hepatic resection after neoadjuvant theraphy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8(4): 347-353, 2001.
2. Cohen AD and Kemeny NE: An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 8(6): 553-566, 2003.
3. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88: 252-258, 1996.
4. Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herudon JE 2nd, Zhang C and Mayer RJ: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481) J Clin Oncol 24(9): 1395-1403, 2006.
5. Simpson D, Dunn C and Curran Goa KL: Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer. Drugs 63(19): 2127-2156, 2003.
6. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Handler D, de Braud F, Wilson C, Morvan F and Bonetti A: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16): 2938-2947, 2000.
7. Goldberg RM, Sargent D J, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts SR: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22(1): 23-30, 2004.
8. Dzodic R, Gomez-Abuin G, Rougier P, Bonnay M, Ardouin P, Gouyette A, Rixe O, Ducreux M and Munck JN: Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model. Anticancer Res 15(6): 647-650, 2004
9. Kern W, Beckert B, Lang N, Stemmler J, Beykirch M, Stein J, Goecke E, Waggershauser T, Braess J, Schalhorn A and Hiddemann W: Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. Ann Oncol 12(5): 599-603, 2001.
10. Mancuso A, Giuliani R, Accettura C, Palma M, D'Auria G, Cecere F, Paoluzzi L, Bezzi M, Massidda B and Cortesi E: Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. Anticancer Res 23(2C): 1917-1922, 2003.
11. Guthoff I, Lotspeich E, Fester C, Wallin I, Schatz M, Ehrsson H and Kornmann M: Hepatic arterial infusion using oxaliplatin in combination with fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Anticancer Res 23(6D): 5203-5208, 2003.
12. Fiorentini G, Rossi S, Dentico P, Meucci F, Bonechi F, Bernardeschi P, Cantore M, Guadagni S and De Simone M: Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study. Anticancer Res 24: 2093-2096, 2004.
13. Hofmann C, Buttenschoen K, Straeter J, Henne-Bruns D and Kornmann M: Pre-clinical evaluation of the activity of irinotecan as a basis for regional chemotherapy. Anticancer Res 25(2A): 795-804, 2005.